TCI Wealth Advisors, Inc. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,876
-33.3%
582
-15.0%
0.00%
-100.0%
Q4 2022$4,309
-38.4%
685
-0.1%
0.00%0.0%
Q3 2022$7,000
-12.5%
686
+0.1%
0.00%0.0%
Q2 2022$8,000
+33.3%
6850.0%0.00%0.0%
Q1 2022$6,000
+20.0%
685
+116.8%
0.00%0.0%
Q4 2021$5,0000.0%316
+64.6%
0.00%0.0%
Q3 2021$5,000
+66.7%
192
+159.5%
0.00%0.0%
Q1 2021$3,000740.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders